---
title: "Eli Lilly maintains M&A streak with $202m Engage Bio buyout"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287202465.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-21T10:22:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287202465.md)
  - [en](https://longbridge.com/en/news/287202465.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287202465.md)
---

# Eli Lilly maintains M&A streak with $202m Engage Bio buyout

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [ECO 2026: tirzepatide shows potential for T1D treatment](https://longbridge.com/en/news/286575591.md)
- [ECO 2026: ATTAIN-MAINTAIN trial showcases orforglipron’s role in sustained weight loss](https://longbridge.com/en/news/286442888.md)
- [Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates](https://longbridge.com/en/news/286890035.md)
- [Investment giants join forces to form largest healthcare firm on the globe](https://longbridge.com/en/news/287091936.md)
- [SERB signs agreement to acquire Idefirix rights for $133.6m](https://longbridge.com/en/news/287041174.md)